Literature DB >> 15094165

Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo.

Eric Brouillette1, Alejandro Martinez, Bobbi J Boyll, Norris E Allen, François Malouin.   

Abstract

Staphylococcus aureus small-colony variants (SCVs) have been implicated in chronic and persistent infections. Bovine mastitis induced by S. aureus is an example of an infection difficult to eradicate by conventional antimicrobial therapies. In this study, the ability to colonize mouse mammary glands and persist under antibiotic treatment was assessed for S. aureus Newbould and an isogenic hemB mutant, which exhibited the classical SCV phenotype. The hemB mutant showed a markedly reduced capacity to colonize tissues. However, although the hemB mutant was as susceptible as S. aureus Newbould to cephapirin in vitro, it was over a 100 times more persistent than the parental strain in the mammary glands when 1 or 2 mg kg(-1) doses were administrated. These results suggest that, although the hemB mutant has a reduced ability to colonize mammary glands, the SCV phenotype may account for the persistence of S. aureus under antibiotic pressure in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094165     DOI: 10.1016/j.femsim.2003.12.007

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  28 in total

1.  sigmaB activity in a Staphylococcus aureus hemB mutant.

Authors:  Maria M Senn; Markus Bischoff; Christof von Eiff; Brigitte Berger-Bächi
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

2.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.

Authors:  Aldona L Baltch; William J Ritz; Lawrence H Bopp; Phyllis Michelsen; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

4.  Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.

Authors:  Lorena P N Tuchscherr; Fernanda R Buzzola; Lucía P Alvarez; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

5.  Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells.

Authors:  Gabriel Mitchell; Mariza Gattuso; Gilles Grondin; Éric Marsault; Kamal Bouarab; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

6.  Altered Competitive Fitness, Antimicrobial Susceptibility, and Cellular Morphology in a Triclosan-Induced Small-Colony Variant of Staphylococcus aureus.

Authors:  Sarah Forbes; Joe Latimer; Abdulrahman Bazaid; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

7.  A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus.

Authors:  Christian Kohler; Christof von Eiff; Manuel Liebeke; Peter J McNamara; Michael Lalk; Richard A Proctor; Michael Hecker; Susanne Engelmann
Journal:  J Bacteriol       Date:  2008-08-01       Impact factor: 3.490

8.  Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.

Authors:  Gabriel Mitchell; David Lalonde Séguin; Ann-Elise Asselin; Eric Déziel; André M Cantin; Eric H Frost; Sophie Michaud; François Malouin
Journal:  BMC Microbiol       Date:  2010-01-30       Impact factor: 3.605

9.  In Vitro Susceptibility of Clinical Staphylococcus aureus Small-Colony Variants to β-Lactam and Non-β-Lactam Antibiotics.

Authors:  Evgeny A Idelevich; André Kriegeskorte; Nina Schleimer; Georg Peters; Christof von Eiff; Karsten Becker
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

10.  Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis.

Authors:  Santiago M Lattar; Lorena P N Tuchscherr; Roberto L Caccuri; Daniela Centrón; Karsten Becker; Claudio A Alonso; Claudia Barberis; Graciela Miranda; Fernanda R Buzzola; Christof von Eiff; Daniel O Sordelli
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.